Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

Company News Summary

Medical Developments International Provides Roadshow Presentation

30 Jun 2020  |  17:36:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: MVP Roadshow Presentation

Medical Developments International provided presentation stating that it has 2 Key operating segments - Pharmaceutical and Medical Devices and also have a significant API development project ongoing in partnership with the CSIRO. The Company updated that Penthrox is a solution to a significant unmet clinical need and market leader for trauma pain wherein 85% of patients reach clinical analgesia within 6-10 breaths. As reported, CRO is ready to commence trial once FDA response received. Also, completion Completion of PASS in Europe is awaiting final Clinical Study Report in Jun/Jul 2020 IND submission targeted for 2021. The Company further updated that it concluded a significant transaction with Daiichi Sankyo for the Chinese, Thai and Vietnamese markets in 2018.

Please click here for full details

See more ASX300 News Announcements